Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Martin Bialik"'
Autor:
Joseph Azuri, Avi Porath, Hadas Rotem Rabinovich, Yaakov Segal, Itzhak Katzir, Rachel Bachar, Yossef Lomnicky, Nava Siegelmann-Danieli, Martin Bialik, Janet Vesterman Landes
Publikováno v:
Breast cancer research and treatment. 167(1)
To evaluate the association between levonorgestrel-releasing intrauterine system (LNG-IUS) use and breast cancer (BC) risk. A cohort of all Maccabi Healthcare Services (MHS) female members aged 40–50 years between 1/2003 and 12/2013 was used to ide
Autor:
Daniel Kurnik, Hillel Halkin, Janet Landes-Westerman, Ronen Loebstein, Noa Markovits, Martin Bialik, Joseph Lomnicky
Publikováno v:
The Journal of Clinical Pharmacology. 54:889-895
Evidence for the association between hypomagnesemia and proton pump inhibitors (PPIs), highlighted by the 2011 FDA Drug Safety Communication, rests mainly on studies in hospitalized patients. Our objectives were to determine the prevalence of hypomag
Autor:
Hillel Halkin, Itzhak Katzir, Janet Vesterman-Landes, Yosef Lomnicky, Ronen Loebstein, Daniel Kurnik, Martin Bialik
Publikováno v:
Clinical Therapeutics. 33:456-464
In controlled trials, dual therapy with angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin receptor blockers (ARBs) is associated with hyperkalemia and decreased renal function, but there is no information about these adverse effects in
Autor:
Ronen Loebstein, Yossi Lomnicky, Daniel Kurnik, Martin Bialik, Nava Siegelmann-Danieli, Janet Vesterman-Landes, Itzhak Katzir
Publikováno v:
Breast Cancer Research and Treatment. 125:505-510
Endoxifen, the most active metabolite of the prodrug tamoxifen, is produced by cytochrome P450 CYP2D6. Breast cancer patients treated with tamoxifen who have reduced CYP2D6 activity, related to either genetic variation or drug inhibition, may have in
Autor:
Noa, Markovits, Ronen, Loebstein, Hillel, Halkin, Martin, Bialik, Janet, Landes-Westerman, Joseph, Lomnicky, Daniel, Kurnik
Publikováno v:
Journal of clinical pharmacology. 54(8)
Evidence for the association between hypomagnesemia and proton pump inhibitors (PPIs), highlighted by the 2011 FDA Drug Safety Communication, rests mainly on studies in hospitalized patients. Our objectives were to determine the prevalence of hypomag
Publikováno v:
Journal of clinical epidemiology. 60(1)
To compare death rates of diabetic men and women relative to the general population and to identify sex-specific risk factors for all-cause mortality.In the current historical prospective cohort study, standardized mortality ratios (SMRs) were calcul
Autor:
Anat Beth-Or, Moshe Leshno, Ran Oren, Shira Zelber-Sagi, Varda Shalev, Zamir Halpern, Revital Kariv, Martin Bialik
Publikováno v:
Hepatology. 38:692-692
Autor:
Siegelmann-Danieli, Nava, Katzir, Itzhak, Landes, Janet Vesterman, Segal, Yaakov, Bachar, Rachel, Rabinovich, Hadas Rotem, Bialik, Martin, Azuri, Joseph, Porath, Avi, Lomnicky, Yossef
Publikováno v:
Breast Cancer Research & Treatment; Jan2018, Vol. 167 Issue 1, p257-262, 6p
Autor:
Markovits, Noa, Loebstein, Ronen, Halkin, Hillel, Bialik, Martin, Landes‐Westerman, Janet, Lomnicky, Joseph, Kurnik, Daniel
Publikováno v:
Journal of Clinical Pharmacology; Aug2014, Vol. 54 Issue 8, p889-895, 7p
Autor:
Siegelmann-Danieli, Nava, Kurnik, Daniel, Lomnicky, Yossi, Vesterman-Landes, Janet, Katzir, Itzhak, Bialik, Martin, Loebstein, Ronen
Publikováno v:
Breast Cancer Research & Treatment; Mar2011, Vol. 125 Issue 2, p505-510, 6p